Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 14 (Search time: 0.022 seconds).
Item hits:
Issue DateTitleAuthor(s)
2013Epigenetics in Friedreich's ataxia: Challenges and opportunities for therapySandi, C; Al-Mahdawi, S; Pook, MA
2012Pms2 suppresses large expansions of the (GAA·TTC)n sequence in neuronal tissuesBourn, RL; De Biase, I; Pinto, RM; Sandi, C; Al-Mahdawi, S; Pook, MA; Bidichandani, S
2012Novel frataxin isoforms may contribute to the pathological mechanism of friedreich ataxiaXia, H; Cao, Y; Dai, X; Marelja, Z; Zhou, D; Mo, R; Al-Mahdawi, S; Pook, MA; Leimkühler, S; Rouault, TA; Li, K
2013Friedreich ataxia patient tissues exhibit increased 5-hydroxymethylcytosine modification and decreased CTCF binding at the FXN locusAl-Mahdawi, S; Sandi, C; Mouro Pinto, R; Pook, MA
2014The emerging role of 5-hydroxymethylcytosine in neurodegenerative diseasesAl-Mahdawi, S; Virmouni, SA; Pook, MA
2014MutLα heterodimers modify the molecular phenotype of Friedreich ataxiaEzzatizadeh, V; Sandi, C; Sandi, M; Anjomani-Virmouni, S; Al-Mahdawi, S; Pook, MA
2014Epigenetic-based therapies for Friedreich ataxiaSandi, C; Sandi, M; Virmouni, SA; Al-Mahdawi, S; Pook, MA
2014Generation and characterisation of Friedreich ataxia YG8R mouse fibroblast and neural stem cell modelsSandi, C; Sandi, M; Jassal, H; Ezzatizadeh, V; Anjomani-Virmouni, S; Al-Mahdawi, S; Pook, MA
2014Cellular, molecular and functional characterisation of YAC transgenic mouse models of Friedreich AtaxiaVirmouni, SA; Sandi, C; Al-Mahdawi, S; Pook, MA
2011Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse modelSandi, C; Pinto, RM; Al-Mahdawi, S; Ezzatizadeh, V; Barnes, G; Jones, S; Rusche, JR; Gottesfeld, JM; Pook, MA